The number of tested samples has increased significantly from a daily average of 230k during the first week of July '20 to over a million daily samples tested by Q4/20 and approx. 700k daily samples in Feb '21. The COVID-19 vaccination programme in India commenced on Jan 16th '21 with 19.5 million vaccine doses administered up to Mar 5. Two vaccines have been approved, ie Covashield (developed by Oxford-AstraZeneca) manufactured by Serum Institure of India and Covaxin (developed by Bharat Biotech in collaboration with ICMR) manufactured by Bharat Biotech.